EGF Protein (AA 974-1026)
Aperçu rapide pour EGF Protein (AA 974-1026) (ABIN2017760)
Antigène
Voir toutes EGF ProtéinesType de proteíne
Activité biologique
Origine
Source
Pureté
-
-
Attributs du protein
- AA 974-1026
-
Attributs du produit
- ED50 < 0.1 ng/mL, measured in a cell proliferation assay using 3T3 cells.
-
niveau d'endotoxine
- < 0.2 EU/μg, determined by LAL method.
-
-
Vous souhaitez d'autres options pour ce Protein ?
!Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
-
Buffer
- Lyophilized after extensive dialysis against PBS.
-
Stock
- -80 °C
-
Stockage commentaire
- Lyophilized recombinant Rat Epidermal Growth Factor remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, Rat Epidermal Growth Factor should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
-
Date de péremption
- 6 months
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Sujet
-
Epidermal Growth Factor, a low-molecular-weight polypeptide, is the founding member of the EGF-family of proteins. It can be found in platelets, macrophages, urine, saliva, etc. EGF acts by binding with high affinity to the Epidermal Growth Factor Receptor (EGFR) and stimulating downstream protein tyrosine kinase activity. This signal transduction cascade results in increased intracellular calcium levels and increased rates of glycolysis and protein synthesis. EGF stimulates the growth of many epidermal and epithelial tissues. Pharmaceutical drugs designed to inhibit EGFR have been used to treat certain types of cancer.
Synonyms: Epidermal Growth Factor, Urogastrone, URG -
Poids moléculaire
- 6 kDa, observed by reducing SDS-PAGE.
-
UniProt
- P07522
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-